A
ACIU
AC Immune SA Common Stock
$2.40
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of AC Immune SA Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$0.43
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: -$0.16
Nov 10
Posts
No posts about ACIU yet.
About AC Immune SA Common Stock
AC Immune is a Swiss biotech company that develops treatments and diagnostics for brain diseases such as Alzheimer's and Parkinson's. It has no approved medicines to sell yet. It earns money mainly from licensing deals and research partnerships, where larger drugmakers pay it upfront fees and milestone payments as its experimental drugs advance.